Search

Your search keyword '"Vulliamy, Tom"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Vulliamy, Tom" Remove constraint Author: "Vulliamy, Tom" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
42 results on '"Vulliamy, Tom"'

Search Results

1. The evolving genetic landscape of telomere biology disorder dyskeratosis congenita

2. New WHO classification of genetic variants causing G6PD deficiency

3. The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

7. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita

11. The Human Phenotype Ontology in 2017

12. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

13. Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants

14. Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita

15. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML

16. P008: ClinGen Glucose-6-phosphate dehydrogenase (G6PD) Variant Curation Expert Panel: Addressing the need for genetic variant classification in G6PD deficiency*

19. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

20. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment

21. Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease

23. Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.

24. Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

25. Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB

27. Phenopolis: an open platform for harmonization and analysis of genetic and phenotypic data

28. Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies

29. The Human Phenotype Ontology in 2017

30. Urinary prostanoids in preschool wheeze

31. Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML

32. The Human Phenotype Ontology in 2017

33. Phenopolis: an open platform for harmonization and analysis of sequencing and phenotype data

34. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer

35. Germline NPM1mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita

37. Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate 5-lipoxygenase (ALOX5) promoter genotype: a multicentre, randomised, placebo-controlled trial

38. GATA2monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML

39. Phenopolis: an open platform for harmonization and analysis of genetic and phenotypic data.

40. Clinical utility gene card for: Dyskeratosis congenita - update 2015.

41. Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy).

42. Urinary prostanoids in preschool wheeze.

Catalog

Books, media, physical & digital resources